先通医药赴港IPO:一款诊断性核药已上市,收入依靠对外授权

新京报
Jun 03, 2025

近日,港交所网站显示,北京先通国际医药科技股份有限公司(简称“先通医药”)已递交上市申请,拟主板挂牌上市,中金公司和中信证券担任联席保荐人。作为国内最早一批从事核药研发的企业之一,先通医药赴港IPO使得人们再次将目光聚焦到核药领域。已有一款诊断性核药上市核药又被称为放射性药物,相比其他药物,结合了制药科学、放射化学与核医学,兼具诊断与治疗双重功能,其所具备的放射性核素可以精准递送至特定生物靶点,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10